Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
Tahmasebi S, El-Esawi MA, Mahmoud ZH, Timoshin A, Valizadeh H, Roshangar L, Varshoch M, Vaez A, Aslani S, Navashenaq JG, Aghebati-Maleki L, Ahmadi M. Tahmasebi S, et al. J Cell Physiol. 2021 Jul;236(7):5325-5338. doi: 10.1002/jcp.30233. Epub 2020 Dec 28. J Cell Physiol. 2021. Retraction in: J Cell Physiol. 2024 Nov;239(11):e31356. doi: 10.1002/jcp.31356 PMID: 33372280 Retracted.
Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, Nazemiyeh M, Aghebati-Maleki L, Jadidi-Niaragh F, Abbaspour-Aghdam S, Roshangar L, Mikaeili H, Ahmadi M. Sadeghi A, et al. Among authors: tahmasebi s. J Cell Physiol. 2021 Apr;236(4):2829-2839. doi: 10.1002/jcp.30047. Epub 2020 Sep 14. J Cell Physiol. 2021. PMID: 32926425
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Tahmasebi S, et al. Life Sci. 2021 Jul 1;276:119437. doi: 10.1016/j.lfs.2021.119437. Epub 2021 Mar 28. Life Sci. 2021. PMID: 33789145 Free PMC article.
Recent advances in antibody-based immunotherapy strategies for COVID-19.
Esmaeilzadeh A, Rostami S, Yeganeh PM, Tahmasebi S, Ahmadi M. Esmaeilzadeh A, et al. Among authors: tahmasebi s. J Cell Biochem. 2021 Oct;122(10):1389-1412. doi: 10.1002/jcb.30017. Epub 2021 Jun 23. J Cell Biochem. 2021. PMID: 34160093 Free PMC article. Review.
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
Marofi F, Rahman HS, Al-Obaidi ZMJ, Jalil AT, Abdelbasset WK, Suksatan W, Dorofeev AE, Shomali N, Chartrand MS, Pathak Y, Hassanzadeh A, Baradaran B, Ahmadi M, Saeedi H, Tahmasebi S, Jarahian M. Marofi F, et al. Among authors: tahmasebi s. Stem Cell Res Ther. 2021 Aug 20;12(1):465. doi: 10.1186/s13287-021-02420-8. Stem Cell Res Ther. 2021. PMID: 34412685 Free PMC article. Review.
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.
Abbaspour-Aghdam S, Hazrati A, Abdolmohammadi-Vahid S, Tahmasebi S, Mohseni J, Valizadeh H, Nadiri M, Mikaeili H, Sadeghi A, Yousefi M, Roshangar L, Nikzad B, Jadidi-Niaragh F, Kafil HS, Malekpour K, Ahmadi M. Abbaspour-Aghdam S, et al. Among authors: tahmasebi s. Eur J Pharmacol. 2022 Oct 15;933:175267. doi: 10.1016/j.ejphar.2022.175267. Epub 2022 Sep 17. Eur J Pharmacol. 2022. PMID: 36122756 Free PMC article. Clinical Trial.
187 results